Toxicity and Antiinflammatory Effect of 1,5-Bis(3’-Ethoxy-4’-Hydroxyphenyl)-1,4- Pentadiene-3-One (EHP)
Abstract
The 1,5-bis(3’-ethoxy-4’-hydroxyphenyl)-1,4-pentadiene -3-one (EHP) is a curcumin analogue. The structure has also been identified before. EHP is obtained, which has been pharmacologically proven to have higher antioxidant activity than curcumin. The objectives of this research were to determine the acute toxicity (LD50) of EHP compound by Weil C.S. method using male mice as experimental animals and to determine its antiinflammatory activity. The LD50 value of the synthesized EHP compound is 6,8675 g/kg body weight (bw) with the criteria of mild toxic, so it is assumed to be safe as drug substance candidate. The anti-inflammatory activity of the compound was determined by obeserved legs swelling index of the mouse. Anti-inflammatory activity of EHP with doses of 137.35 mg, 274.70 mg and 549.40 mg were equal to aspirin with the dose of 90 mg/200 g bw
References
2. Sardjiman SS, Samhoedi M, Hakim L, Vandergoot H, Timmerman H. Synthesis and structure activity relationship 1,5-diphenyl-1,4-pentadien-3-ones-and cycly analogues an antioxidative agent. Yogyakarta: Faculty of Pharmacy, Gadjah Mada University; 2003. 175-84.
3. Esti M, Indriana P, Evi L, Enjang R. Sintesis dan uji antioksidan senyawa 1,5-bis(3’-etoksi- 4’-hidroksifenil)-1,4-pentadien-3-on. Jurnal Ilmu Kefarmasian Indonesia. 2010. 8(2): 93-102. 4. Esti M, Agus N, Mayagustina A, Bambang SAS. The molecular docking of 1,5-diphenil-1,4-pentadien-3- on derivates as the inhibitor of COX-2 enzyme. Henk
Timmerman International Seminar& Awards (HTSIA) on Structure Based Drug Design, Yogyakarta, 2009.
5. Esti M, Budi I, Mayagustina A, Bambang SAS. Docking molekul derivat 1,5-difenil-1,4-pentadien- 3-on sebagai inhibitor enzim LOX-5. Seminar dan Kongres Nasional ISFI, Jakarta, 2009.
6. Lu FC. Toksikologi, dasar asas, organ sasaran, dan penelitian resiko. Edisi 2. Diterjemahkan oleh Edi Nugroho. Jakarta: UI Press; 1995.
7. Weil CS. Table for convinent calculation of median effective dose (LD50) and instruction in their use biometrics. 1952.
Licence
Copyright @2017. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted non-commercial used, distribution and reproduction in any medium
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.